Case Study 6 – Major Pharma Client

• Celtic Catalysts undertook synthesis of a potentially mutagenic impurity of contained in client’s pipeline drug .
• Celtic Catalysts subsequently produced 100s of grams of a metabolite and other impurities.
• Celtic Catalysts designed a protocol and ran analysis to enable quantification of this impurity in batch runs.
• Subsequently redeveloped a key step of the process to avoid any chance of producing this impurity